A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2

Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaleb B. Tsegay (Author), Christiana M. Adeyemi (Author), Edward P. Gniffke (Author), D. Noah Sather (Author), John K. Walker (Author), Stephen E. P. Smith (Author)
Format: Book
Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available